The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest autoinjectors market share, and Asia-Pacific was the fastest-growing region in 2022.

The global autoinjectors market is expected to grow from $2.47 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 21.9%. The autoinjectors market size is expected to grow to $6.51 billion in 2027 at a CAGR of 21.3%.

Major Driver In The Autoinjectors Market ­– Increase In The Prevalence Of Chronic Diseases
According to Imperial College London research, chronic diseases are estimated to kill about 41 million people globally each year by 2020, accounting for seven out of 10 fatalities. Around 17 million of these deaths are categorised as premature, with people dying at a much younger age than expected on average. As a result, the rising prevalence of chronic diseases propels the autoinjectors market forward.

View More On The Autoinjectors Market Report 2023 – https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

Key Autoinjectors Market Segments
1) By Type: Disposable Autoinjectors, Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies
3) By Route Of Administration: Subcutaneous, Intramuscular
4) By Distribution Channel: Online Retailer, Pharmacy
5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

Recent Autoinjectors Market Trend – Technological Advancement
Major participants in the autoinjectors sector are concentrating on creating technology solutions for autoinjectors in order to address the demand for a viscous biologics delivery mechanism. For example, Becton Dickinson (BD), a US-based medical device manufacturer, is developing Intevia 2.25 mL based on thinner wall cannula technology in February 2021. The Intevia 2.25 mL is a patient-centric device with an 8-millimeter needle with a thinner wall that works smoothly with BD Neopak XtraFlow prefillable syringes.

Autoinjectors Market Prominent Players
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca.

Request A Sample Of The Global Autoinjectors Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

The Autoinjectors Global Market Report 2023  provides a comprehensive overview on the autoinjectors market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

An autoinjector is a device that injects a single, predetermined dose of medication into the user’s body. It is typically made up of a spring-loaded syringe that is activated when the gadget is forcefully pressed on the body.

View More Related Reports –
Wearable Injectors Global Market Report 2023
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2023
Contrast Media Injectors Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model